CU-3 is a DGKalpha inhibitor with an IC50 of 0.6 µM. CU-3 competitively reduces DGKalphas affinity for ATP via binding to the enzymes catalytic region. CU-3 induces apoptosis in cancer cells. CU-3 promotes T-cell activation and enhances IL-2 production. CU-3 can be used for the research of hepatocellular carcinoma and cervical cancer[1].
Molekulargewicht:
392.47
CAS Nummer:
[2983265-35-4]
Formel:
C16H12N2O4S3
Target-Kategorie:
Apoptosis,Caspase,DGK,Interleukin Related
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
